Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain.
Saved in:
| Title: | Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain. |
|---|---|
| Authors: | Nieto‐Cid, María1,2 (AUTHOR), Garriga‐Baraut, Teresa3 (AUTHOR), Plaza‐Martín, Ana Mª.4 (AUTHOR), Tortajada‐Girbés, Miguel5,6,7 (AUTHOR), Torres‐Borrego, Javier8 (AUTHOR), Lozano‐Blasco, Jaime4 (AUTHOR), Moreno‐Galarraga, Laura9 (AUTHOR), del Mar Folqué‐Giménez, Mª.4 (AUTHOR), Bosque‐García, Montse10 (AUTHOR), Gaboli, Mirella11 (AUTHOR), López‐Neyra, Alejandro12 (AUTHOR), Rivas‐Juesas, Cristina13 (AUTHOR), Caballero‐Rabasco, Mª. Araceli14 (AUTHOR), Freixa‐Benavente, Andrea3 (AUTHOR), Valdesoiro‐Navarrete, Laura10 (AUTHOR), de Mir‐Messa, Inés3 (AUTHOR), Ballester‐Asensio, Esther5,6 (AUTHOR), Penín‐Antón, María15 (AUTHOR), Romero‐García, Raquel16 (AUTHOR), Navarro‐Morón, Juan17 (AUTHOR) |
| Source: | Pediatric Allergy & Immunology. Apr2023, Vol. 34 Issue 4, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
